During the past decade, Drug Research and Analysis Corp conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drug Research and Analysis Corp" #1 sponsor was "Melinta Therapeutics, Inc." with 2 trials, followed by "Ortho-Clinical Diagnostics, Inc." with 2 trials sponsored, "Pacira Pharmaceuticals, Inc" with 2 trials sponsored, "AMAG Pharmaceuticals, Inc." with 1 trials sponsored and "AcelRx Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Research and Analysis Corp" #1 collaborator was "Registrat-Mapi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Drug Research and Analysis Corp" are "Osteoarthritis" (2 trials), "Pain, Postoperative" (2 trials), "Postoperative Pain" (2 trials), "Abscess" (1 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Drug Research and Analysis Corp" in a lesser frequency.

Most popular intervention types in "Drug Research and Analysis Corp" are "Drug" (18 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "Bupivacaine HCl" (2 trials), "Linezolid" (2 trials), "Placebo" (2 trials) and "SKY0402" (2 trials). Other intervention names were less common.

The vast majority of trials in "Drug Research and Analysis Corp" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Drug Research and Analysis Corp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Drug Research and Analysis Corp, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Drug Research and Analysis Corp, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".